AstraZeneca Pharma India appoints Gagan Singh Bedi as MD
New Delhi: Drug firm AstraZeneca Pharma India on Thursday said Gagan Singh Bedi will take over as the Managing Director of the company with effect from July 1.
The company has accepted resignation of Sanjay Murdeshwaras MD and as a director. He is shifting to a global role within the AstraZeneca group, based in Gaithersburg, Maryland, US, AstraZeneca Pharma India said in a filing to BSE.
"The Board has co-opted Gagan Singh Bedi as additional director on the board, who will take over as the Managing Director of the company with effect from July 1, 2017," it added.
Singh had joined AstraZeneca Pharma India in February 2006.
Prior to joining AstraZeneca, he had worked with Baxter India and Eli Lilly.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd